Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia Relapse-Reference-Cited by-同舟云学术

Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia Relapse

Published:2018-12 Issue:12 Volume:18 Page:e521-e527
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Mashima Kiyomi^ORCID,Oh Iekuni,Ikeda Takashi,Toda Yumiko,Ito Shoko,Umino Kento,Minakata Daisuke,Nakano Hirofumi,Morita Kaoru,Yamasaki Ryoko,Kawasaki Yasufumi,Sugimoto Miyuki,Yamamoto Chihiro,Ashizawa Masahiro,Fujiwara Shin-Ichiro,Hatano Kaoru,Sato Kazuya,Omine Ken,Muroi Kazuo,Kanda Yoshinobu^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference39 articles.

1. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study;Sant;Lancet Oncol,2014

2. Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia;Percival;Blood Rev,2017

3. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Dohner;Blood,2017

4. WT1 monitoring in core binding factor AML: comparison with specific chimeric products;Lasa;Leuk Res,2009

5. Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype;Schnittger;Blood,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wilms’ tumor gene 1 in hematological malignancies: friend or foe?;Hematology;2023-09-05

2. Prognostic value of combined WT1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia;Scandinavian Journal of Clinical and Laboratory Investigation;2023-06-24

3. Prognostic value of the WT-1 gene combined with recurrent cytogenetic genes in acute myeloid leukemia;Immunogenetics;2023-06-22

4. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia;Clinical and Translational Oncology;2023-01-04

5. Prognostic value of WT-1 gene combined with recurrent cytogenetic gene in acute myeloid leukemia;2022-10-25